Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes

Josyf C. Mychaleckyj, Erkka Valo, Takaharu Ichimura, Tarunveer S. Ahluwalia, Christian Dina, Rachel G. Miller, Ivan G. Shabalin, Beata Gyorgy, JingJing Cao, Suna Onengut-Gumuscu, Eiichiro Satake, Adam M. Smiles, Jani K. Haukka, David-Alexandre Tregouet, Tina Costacou, Kristina O'Neil, Andrew D. Paterson, Carol Forsblom, Hillary A. Keenan, Marcus G. PezzolesiMarlon Pragnell, Andrzej Galecki, Stephen S. Rich, Niina Sandholm, Ronald Klein, Barbara E. Klein, Katalin Susztak, Trevor J. Orchard, Ron Korstanje, George L. King, Samy Hadjadj, Peter Rossing, Joseph V. Bonventre, Per-Henrik Groop, James H. Warram, Andrzej S. Krolewski

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of the American Society of Nephrology
Volume32
Issue number10
Pages (from-to)2634-2651
Number of pages18
ISSN1046-6673
DOIs
Publication statusPublished - Oct 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • type 1 diabetes
  • hydroxysteroid 17-beta dehydrogenase 14
  • end stage kidney disease
  • gene-based tests
  • rare variants
  • diabetic nephropathy
  • diabetic kidney disease
  • GENOME-WIDE ASSOCIATION
  • RENAL DECLINE
  • NEPHROPATHY
  • COMPLICATIONS
  • RISK
  • MICROALBUMINURIA
  • PREDICTORS
  • GENETICS
  • DURATION
  • GENES
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this